Following second-quarter earnings, leading global brokerages have overhauled targets across Indian equities, issuing sell calls on Voltas, downgrading Britannia, and upgrading Divi's Labs.

Dalal Street witnessed a flurry of high-stakes rating revisions as leading global and domestic institutional brokerages updated their financial models following the second-quarter earnings season. After extensive discussions with corporate managements and granular dissection of balance sheets, marquee brokerage houses including Goldman Sachs, JP Morgan, Citi, Nomura, Jefferies, and CLSA have issued decisive calls across more than ten key equities. The market response has revealed a stark divergence: while pharma major Divi’s Laboratories, state-owned upstream giant ONGC, fast-food operator Jubilant FoodWorks, and precision manufacturer Azad Engineering secured aggressive target upgrades, consumer staples and durable leaders faced severe valuation pushback. In particular, room air conditioner market leader Voltas was hit with an outright 'Sell' rating due to margin contraction, while FMCG bellwether Britannia Industries was downgraded amid persistent raw material cost pressures.

Divi’s Laboratories Surges on Strong CDMO Pipeline and Margin Expansion

Pharma heavyweight Divi’s Laboratories emerged as the standout performer of the quarter, posting financial results that comfortably surpassed Dalal Street consensus estimates. The active pharmaceutical ingredient (API) and custom synthesis specialist reported a 35 percent year-on-year surge in consolidated revenue to ₹3,676 crore, while its earnings before interest, taxes, depreciation, and amortization (EBITDA) leaped 76 percent year-on-year to ₹1,566 crore. Driving this performance was a remarkable 989-basis-point expansion in operating margins to 42.6 percent, propelled by an optimized product mix, growing economies of scale, and captive backward integration for critical raw materials. The custom synthesis business demonstrated extraordinary momentum, climbing 54 percent year-on-year on the back of validation batch supplies for global pharmaceutical innovators.

Institutional response to Divi’s performance was emphatically bullish. Global investment bank JP Morgan reiterated its 'Overweight' stance, raising its target price to ₹12,500 per share while revising earnings estimates upward by 18 to 30 percent across fiscal years 2027 to 2029. Goldman Sachs maintained a 'Buy' rating with a revised price target of ₹11,700, underscoring that three dedicated contract development and manufacturing organization (CDMO) programs are approaching late-stage commercialization. Analysts also pointed to the company’s capital expenditure in peptide production—specifically the installation of multiple 3,000-liter solid-phase peptide synthesis (SPPS) reactors—which positions Divi's to become one of the top three integrated peptide manufacturers globally as GLP-1 opportunities accelerate.

Cooling Margins Trigger Voltas Sell Call as Britannia Faces Downgrade

In sharp contrast to the pharmaceutical rally, consumer durables bellwether Voltas faced heavy institutional skepticism regarding the sustainability of its operating profitability. Goldman Sachs slapped a 'Sell' rating on the Tata Group company with a target price of ₹1,025, pointing out that while consolidated revenue matched Street expectations, bottom-line profitability and underlying EBITDA quality were notably weak. Despite strong market share and robust volume growth in the unitary cooling products (UCP) segment, the expected margin recovery failed to materialize due to heightened competitive pricing. Nomura retained a 'Neutral' stance with a target of ₹1,199, trimming its UCP margin estimates by 100 to 130 basis points through fiscal 2029 and warning that aggressive price battles will likely push margin normalization into the late fourth quarter despite recent price hikes.

The fast-moving consumer goods sector reflected similar margin distress, prompting Jefferies to downgrade biscuit manufacturer Britannia Industries from 'Buy' to 'Hold' with a target price of ₹5,350. Although Britannia delivered a healthy 13 percent growth in underlying sales volumes, relentless cost inflation across critical raw materials—primarily palm oil, wheat flour, and dairy inputs—has compressed gross margins. Analysts noted that management’s dilemma between implementing price hikes or reducing pack grammage carries the immediate risk of denting volume elasticity, especially among price-sensitive rural consumers, leading the brokerage to cut its three-year forward earnings estimates by 3 percent.

Bharti Airtel Navigates Tariff Realities While Tata Steel Eyes Domestic Gains

Telecom titan Bharti Airtel presented a complex narrative that drew divergent commentary from major institutional desks. Both Citi and Nomura retained their 'Buy' recommendations, fixing price targets of ₹2,390 and ₹2,375 respectively, but highlighted friction in the wake of recent pricing adjustments. The telecom operator's decision to reintroduce the ₹299 entry-tier prepaid plan with reduced daily data allowances—offering 1GB per day compared to the previous 1.5GB—served as a test case for subscriber elasticity. Citi highlighted that following the tariff revisions, monthly churn ticked up from 2.6 percent to 2.9 percent, while net subscriber additions tapered sharply from 3.3 million to 0.7 million. While the company's industry-leading average revenue per user (ARPU) expanded to ₹271, providing a roughly 2 percent revenue accretion, analysts cautioned that independent tariff increases without synchronized industry-wide moves could elevate the risk of subscriber migration. Conversely, Nomura remained optimistic, arguing that structural tailwinds across enterprise connectivity, home broadband fiber installations, and the high-margin data center subsidiary will sustain mid-term earnings compounding alongside robust African business operations.

In the industrial commodities space, Tata Steel drew contrasting perspectives centered on geographical divergence. CLSA maintained an 'Outperform' rating with a target price of ₹225, highlighting that a 14 percent sequential EBITDA expansion was driven by firm domestic deliveries and operational resilience in the Netherlands, effectively neutralizing ongoing restructuring losses in the United Kingdom. With domestic steel realizations expected to climb by approximately ₹3,500 per tonne in the third quarter, analysts expect Indian operations to offset elevated coking coal expenditure, projecting the UK business to achieve cash break-even by the final quarter of fiscal 2027. Taking a more cautious stance, Goldman Sachs maintained a 'Neutral' rating with a target of ₹215, observing that subdued European demand could complicate operational turnarounds, leaving near-term earnings heavily dependent on downstream product mix until newly expanded capacity at Neelachal Ispat Nigam Limited (NINL) begins full commercial contribution.

Energy and Quick-Service Giants Benefit from Growth Momentum

State-run upstream producer Oil and Natural Gas Corporation (ONGC) secured a 'High Conviction Outperform' rating from CLSA, accompanied by a target price of ₹405. Although standalone net profit slipped 5 percent below consensus due to one-off impairment provisions, the core operating numbers told a different story: operating EBITDA and core earnings beat expectations by 7 percent and 4 percent, respectively. Investor sentiment was further bolstered by the declaration of an interim dividend of ₹8 per share, translating into an annualized dividend yield of roughly 3.5 percent. The brokerage highlighted significant volume upsides anticipated from the offshore KG-DWN-98/2 deepwater basin and Daman development projects across fiscal years 2027 and 2028, projecting total returns approaching 76 percent assuming stable global crude benchmarks near $82 per barrel.

In the quick-service restaurant (QSR) space, Jubilant FoodWorks garnered an 'Outperform' rating from CLSA with a target price of ₹550. The master franchisee reported an 11.5 percent jump in standalone revenue, supported by a 4.1 percent like-for-like (LFL) sales growth across its core Domino’s India stores. Operating margins expanded to 19.8 percent, while Popeyes chicken outlets demonstrated explosive traction, delivering a 53 percent same-store sales jump and a 122 percent surge in top-line revenue. With innovative menu items approaching double-digit contributions to overall revenue, analysts expressed confidence in the company’s ability to meet its full-year 5 to 7 percent like-for-like growth guidance.

Sharp Polarization in Mid-Caps: Honasa Consumer, Gland Pharma, and Capital Goods

The mid-cap and consumer internet landscape revealed intense analytical polarization, best illustrated by beauty brand operator Honasa Consumer. Jefferies reaffirmed a high-conviction 'Buy' on the Mamaearth parent company, lifting its target price to ₹700 on the back of 36 percent revenue growth and a 95 percent surge in EBITDA. The brokerage praised the rapid scaling of younger portfolio brands like The Derma Co., which clocked growth exceeding 45 percent. In contrast, Citi maintained a resolute 'Sell' call with a target of ₹390, sounding alarms over excessive marketing burn—with advertising expenses swallowing 33.5 percent of total revenue—and gross margin contraction, warning that a valuation multiple of 49 times fiscal 2028 projected earnings leaves zero room for execution missteps.

A similar divergence unfolded for injectable manufacturer Gland Pharma. While Nomura assigned a 'Buy' with a target of ₹3,790, citing a 23 percent revenue recovery led by the core US market and substantial brownfield expansion in its CDMO division, Citi issued a 'Sell' rating at ₹2,360, pointing to sequential operating margin erosion and temporary shutdowns at international facilities. Meanwhile, precision aerospace engineering supplier Azad Engineering won a 'Buy' rating from Goldman Sachs with a target of ₹3,125, supported by 31 percent top-line expansion and management’s roadmap to double revenue to ₹1,300 crore by FY28. Capital goods player Siemens India secured a 'Neutral' stance from Citi at ₹3,875 following a strong order backlog of ₹47,000 crore, while industrial equipment manufacturer Thermax was maintained at 'Buy' by Jefferies with a trimmed target of ₹4,020 after component inflation and supply chain deferrals caused an operating miss. As corporate India enters the second half of the financial year, the dramatic dispersion in brokerage ratings underscores that operational execution, pricing power, and strict margin discipline will dictate equity trajectories across domestic markets.